PapersFlow Research Brief
High Altitude and Hypoxia
Research Guide
What is High Altitude and Hypoxia?
High altitude and hypoxia refers to the genetic and physiological adaptations of humans and other vertebrates to low-oxygen environments at high altitudes, encompassing responses such as acute mountain sickness, erythropoietin regulation, oxidative stress, pulmonary edema, and endurance training effects.
Research on high altitude and hypoxia includes 58,036 works examining molecular, systemic, and cellular responses to hypoxic conditions. Key focuses involve hypoxia-inducible factors (HIFs) that regulate oxygen homeostasis and gene expression under low oxygen. Studies also address mitochondrial reactive oxygen species (ROS) production and its role in stabilizing HIF-1α during hypoxia.
Topic Hierarchy
Research Sub-Topics
Genetic Adaptations to High Altitude Hypoxia
Researchers perform GWAS and comparative genomics on highland populations like Tibetans and Andeans to identify hypoxia-tolerance variants. Studies elucidate EPAS1 and EGLN1 roles in evolutionary adaptation.
Hypoxia-Inducible Factor Signaling Pathways
This area dissects HIF-1α/2α stabilization, PHD hydroxylases, and VHL-mediated degradation under low oxygen. Mechanistic studies link pathway dysregulation to cancer and ischemia.
High Altitude Pulmonary Edema Pathophysiology
Investigations examine hypoxic pulmonary vasoconstriction, capillary leak, and inflammation causing HAPE. Clinical studies test pharmacological preventives like nifedipine and acetazolamide.
Erythropoietin Response to Hypobaric Hypoxia
Research quantifies EPO upregulation, hematocrit changes, and polycythemia risks during altitude exposure. Studies differentiate sea-level from hypobaric hypoxia responses.
Oxidative Stress in High Altitude Physiology
Scientists measure ROS production from mitochondrial uncoupling and antioxidant defenses in hypoxia. Interventions test vitamins and training mitigating oxidative damage.
Why It Matters
Understanding high altitude and hypoxia informs treatments for conditions like acute mountain sickness and pulmonary edema through insights into erythropoietin response and oxidative stress management. Gregg L. Semenza (2012) in "Hypoxia-Inducible Factors in Physiology and Medicine" details HIF roles in physiology and medicine, aiding therapies for hypoxic diseases. William G. Kaelin and Peter J. Ratcliffe (2008) in "Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway" explain oxygen sensing mechanisms, with applications in cancer and inflammation as noted by Holger K. Eltzschig and Peter Carmeliet (2011) in "Hypoxia and Inflammation", where local hypoxia links to inflammatory disorders. The NOCTURNAL OXYGEN THERAPY TRIAL GROUP (1980) demonstrated in "Continuous or Nocturnal Oxygen Therapy in Hypoxemic Chronic Obstructive Lung Disease" that continuous oxygen therapy extended survival in 203 hypoxemic patients followed for a mean of 19.3 months compared to nocturnal therapy.
Reading Guide
Where to Start
"Hypoxia-Inducible Factors in Physiology and Medicine" by Gregg L. Semenza (2012) provides a foundational overview of HIF roles in physiology and medicine, making it ideal for initial reading due to its broad scope and 3241 citations.
Key Papers Explained
Gregg L. Semenza (2012) "Hypoxia-Inducible Factors in Physiology and Medicine" builds on his earlier work Gregg L. Semenza (1999) "Regulation of Mammalian O2 Homeostasis by Hypoxia-Inducible Factor 1", expanding HIF-1 regulation details. William G. Kaelin and Peter J. Ratcliffe (2008) "Oxygen Sensing by Metazoans: The Central Role of the HIF Hydroxylase Pathway" connects by detailing the sensing mechanism upstream of HIF activation. Navdeep S. Chandel et al. (2000) "Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia" and Laura A. Sena and Navdeep S. Chandel (2012) "Physiological Roles of Mitochondrial Reactive Oxygen Species" link ROS production to HIF stabilization, forming a progression from sensing to transcriptional response.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Current frontiers center on genetic adaptations and physiological responses in high-altitude vertebrates, with 58,036 works emphasizing erythropoietin, oxidative stress, and pulmonary edema. No recent preprints or news coverage indicate focus remains on established HIF and ROS pathways from top papers like Amar J. Majmundar et al. (2010) "Hypoxia-Inducible Factors and the Response to Hypoxic Stress".
Papers at a Glance
| # | Paper | Year | Venue | Citations | Open Access |
|---|---|---|---|---|---|
| 1 | Hypoxia-Inducible Factors in Physiology and Medicine | 2012 | Cell | 3.2K | ✓ |
| 2 | Oxygen Sensing by Metazoans: The Central Role of the HIF Hydro... | 2008 | Molecular Cell | 3.1K | ✓ |
| 3 | Physiological Roles of Mitochondrial Reactive Oxygen Species | 2012 | Molecular Cell | 2.5K | ✓ |
| 4 | Hypoxia-Inducible Factors and the Response to Hypoxic Stress | 2010 | Molecular Cell | 2.3K | ✓ |
| 5 | Continuous or Nocturnal Oxygen Therapy in Hypoxemic Chronic Ob... | 1980 | Annals of Internal Med... | 2.1K | ✕ |
| 6 | Hypoxia and Inflammation | 2011 | New England Journal of... | 2.0K | ✕ |
| 7 | Regulation of Mammalian O<sub>2</sub>Homeostasis by Hypoxia-In... | 1999 | Annual Review of Cell ... | 1.9K | ✕ |
| 8 | Reactive Oxygen Species Generated at Mitochondrial Complex III... | 2000 | Journal of Biological ... | 1.9K | ✓ |
| 9 | Mitochondrial reactive oxygen species trigger hypoxia-induced ... | 1998 | Proceedings of the Nat... | 1.9K | ✓ |
| 10 | Prevalence and Ethnic Pattern of Diabetes and Prediabetes in C... | 2017 | JAMA | 1.9K | ✓ |
Frequently Asked Questions
What is the role of hypoxia-inducible factor 1 (HIF-1) in oxygen homeostasis?
HIF-1 is a heterodimeric transcription factor with HIF-1α and HIF-1β subunits whose activity increases exponentially as cellular oxygen decreases. Gregg L. Semenza (1999) in "Regulation of Mammalian O2 Homeostasis by Hypoxia-Inducible Factor 1" showed it regulates dozens of target genes including those for erythropoietin and glycolytic enzymes. This response enables adaptation to hypoxia by enhancing oxygen delivery and metabolism.
How do mitochondrial reactive oxygen species contribute to hypoxia responses?
Mitochondrial ROS generated at complex III stabilize HIF-1α during hypoxia, triggering transcription of genes like erythropoietin. Navdeep S. Chandel et al. (2000) in "Reactive Oxygen Species Generated at Mitochondrial Complex III Stabilize Hypoxia-inducible Factor-1α during Hypoxia" demonstrated this mechanism in cells. Navdeep S. Chandel et al. (1998) in "Mitochondrial reactive oxygen species trigger hypoxia-induced transcription" confirmed ROS mediate hypoxic induction of glycolytic enzymes and vascular endothelial growth factor.
What are the physiological roles of mitochondrial ROS?
Mitochondrial ROS act as signaling molecules in processes like oxygen sensing and hypoxic adaptation beyond damage. Laura A. Sena and Navdeep S. Chandel (2012) in "Physiological Roles of Mitochondrial Reactive Oxygen Species" outlined their roles in cellular signaling. This includes stabilization of HIF-1α as shown in related high-citation works on hypoxia.
How does hypoxia link to inflammation?
Hypoxia associates with inflammation in diseases through HIF-mediated pathways and local oxygen deficits. Holger K. Eltzschig and Peter Carmeliet (2011) in "Hypoxia and Inflammation" reviewed evidence for this connection in conditions like cancer. Targeting intralesional hypoxia offers potential for treating inflammatory disorders.
What oxygen therapy is effective for hypoxemic chronic obstructive lung disease?
Continuous oxygen therapy outperforms nocturnal therapy in survival for hypoxemic patients. The NOCTURNAL OXYGEN THERAPY TRIAL GROUP (1980) in "Continuous or Nocturnal Oxygen Therapy in Hypoxemic Chronic Obstructive Lung Disease" randomized 203 patients across six centers, with continuous therapy followed for a mean of 19.3 months showing better outcomes. This applies to chronic hypoxia management relevant to high-altitude contexts.
Open Research Questions
- ? How do variations in HIF hydroxylase pathways influence individual susceptibility to acute mountain sickness?
- ? What specific genetic adaptations mitigate oxidative stress from mitochondrial ROS at high altitudes?
- ? How does endurance training modulate erythropoietin responses in vertebrate high-altitude adaptation?
- ? What cellular mechanisms link pulmonary edema to hypoxia-inducible factor dysregulation?
- ? How do systemic inflammation pathways interact with local hypoxia in high-altitude pulmonary conditions?
Recent Trends
The field encompasses 58,036 works on high altitude and hypoxia with no specified 5-year growth rate.
High-citation papers from 1998-2012, such as Gregg L. Semenza with 3241 citations and William G. Kaelin and Peter J. Ratcliffe (2008) with 3141 citations, dominate, reflecting sustained interest in HIF pathways.
2012Absence of recent preprints or news indicates no major shifts in the past 6-12 months.
Research High Altitude and Hypoxia with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching High Altitude and Hypoxia with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers